Genipin cross-linked fibrin gels
The invention provides a genipin cross-linked fibrin gel. The ratio of genipin to fibrin in the gel ranges from about 0.1:1 to about 10:1 (genipin:fibrin). The gel can be hydrogel. Also provided is method for repairing tissue defects by administering the gel to site of tissue defect.
1. A genipin cross-linked fibrin gel for repairing defects in a intervertebral disc annulus, the gel having a genipin:fibrin ratio of 0.1:1 to 2:1, where the gel is made with a fibrin solution comprising from 250 mg/ml to 400 mg/ml of fibrin.
2. The gel of claim 1 , wherein gel has a shear modulus of from about 50 kPa to about 110 kPa.
3. The gel of claim 1 , wherein the gel further comprises a bioactive agent.
4. The gel of claim 3 , wherein the bioactive agent is a therapeutic agent.
5. The gel of claim 3 , wherein the bioactive agent is a wound healing agent.
6. The gel of claim 1 , wherein the gel further comprises a cell.
7. The gel of claim 6 , wherein the cell is mammalian cell.
8. The gel of claim 6 , wherein the cell is a human cell.
9. The gel of claim 6 , wherein the cell is a disc cell.
10. The gel of claim 1 , wherein the gel is functionalized with an affinity binding molecule, wherein the affinity molecule binds with a bioactive molecule.
11. The gel of claim 10 , wherein the affinity molecule is selected from the group consisting of antibodies, antigens; lectins; proteins; peptides; nucleic acids; receptor molecules; and ligands for receptors.
12. The gel of claim 10 , wherein the affinity molecule binds with a cell.
13. A method of repairing a tissue defect in an intervertebral disc annulus in a subject in need thereof, the method comprising placing a gel of claim 1 at a tissue defect site in the subject.
14. The method of claim 13 , wherein the tissue defect is selected from the group consisting of wounds, ulcers, burns, natural defects, and any combinations thereof.
15. The method of claim 13 , wherein the tissue defect is caused by traumatic injury, disease, infection, surgical intervention, natural causes, or any combinations thereof.
16. The method of claim 13 , wherein the tissue defect is an intervertebral disc annulus defect.
17. The method of claim 13 , wherein the subject is a mammal.
18. The method of claim 13 , wherein the subject is human.